The impact of human rights violations and perceptions of discrimination on health service utilization among injection drug users in Delhi, India

Substance Use and Misuse

Volumn 47, Issue 3, 2012, Pages 230-243

  Sarin, Enisha ^a   Kerrigan, Deanna ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Harm reduction; Health service utilization; HIV AIDS; Human rights; India; Injection drug users

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DRUG USE; HARM REDUCTION; HEALTH SERVICE; HUMAN; HUMAN RIGHTS ABUSE; INDIA; MIDDLE AGED; PSYCHOLOGICAL ASPECT; SOCIAL PSYCHOLOGY; SUBSTANCE ABUSE; UTILIZATION REVIEW;

ADOLESCENT; ADULT; DRUG USERS; HARM REDUCTION; HEALTH SERVICES; HUMAN RIGHTS ABUSES; HUMANS; INDIA; MIDDLE AGED; PREJUDICE; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84855504392     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2011.631676     Document Type: Article

References (60)

1. Aciejas, C., Friedman, S. R., Cooper, H. L. F., Wiessing, L., Stimson, G. V., & Hickman, M. (2006). Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution. Sex Transm Infect, 82, (Suppl 3): iii10-iii17. (Pubitemid 43901606)
2. Aitken, C. M. D., Higgs, P., Kersall, J., & Kerger, M. (2002). The impact of a police crackdown on a street drug scene: Evidence from the street. International Journal of Drug Policy, 13, 189-198. (Pubitemid 35283752)
3. Anema, A., Vogenthaler, N., Frongillo, E. A., Kadiyala, S., & Weiser, S. D. (2009). Food insecurity and HIV/AIDS: Current knowledge, gaps, and research priorities. Current HIV/AIDS Reports, 6(4), 224-231.
4. Bastos, F. I., & Strathdee, S. A. (2000). Evaluating effectiveness of syringe exchange programmes: Current issues and future prospects. Social Science and Medicine, 51, 1771-1782.
5. Best, D. S. J., Beswick, T., & Gossop, M. (2001). Assessment of a concentrated high-profile police operation: No discernible impact on drug availability price or purity. British journal of Criminology, 41, 738-745.
6. Bluthenthal, R. N., Kral, A. H., Erringer, E. A., & Edlin, B. R. (1999). Drug paraphernalia laws and injection related infectious disease risk among drug injectors. Journal of Drug Issues, 29, 1-16. (Pubitemid 29202658)
7. Bluthenthal, R. N., Kral, A. H., Gee, L., Erringer, E. A., & Edlin, B. R. (2000). The effect of syringe exchange use on high-risk injection drug users: A cohort study. Acquired Immune Deficiency Syndromes, 14, 605-611.
8. Callon, C., Wood, E., Marsh, D., Li, K., Montaner, J., & Kerr, T. (2006). Barriers and facilitators to methadone maintenance therapy use among illicit opiate injecting drug users in Vancouver. Journal of Opioid Management, 2(1), 35-41.
9. Charles, M., Bewley-Tailor, D., & Neidpath, A. (2005). Drug policy in India: Compounding harm? The Beckley Foundation Drug Policy Programme. Retrieved March 20, 2010, from www.internationaldrugpolicy.net/reports/ BeckleyFoundation BreifingPaper 10
10. Chatterjee, A., & Sharma, M. (2010).Moving from a project to programmatic response: Scaling up harm reduction in Asia. International Journal of Drug Policy, 21, 134-136.
11. Chilton, M., & Rose, D. (2009). A rights based approach to food security in the United States. American Journal of Public Health, 99(7), 1203-1211. Epub May 14, 2009.
12. Darke, S., Topp, I., Kaye, H., & Hall,W. (2002). Heroin use in New SouthWales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the illicit drug reporting system. Addiction, 97(2), 179-186. (Pubitemid 34112376)
13. Davis, C. S., Burris, S., Kraut-Becher, J., Lynch, K. G., & Metzger, D. (2005). Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA. American Journal of Public Health, 95(2), 233-236. (Pubitemid 40179818)
14. DeBeck, K., Wood, E., Zhang, R., Tyndall, M., Montaner, J., & Kerr, T. (2008). Police and public health partnerships: Evidence from the evaluation of Vancouver's supervised injection facility. Substance Abuse Treatment, Prevention, and Policy, 3(1), 11.
15. Emmanuel, F., & Fatima, M. (2008). Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: Delivering prevention services where most needed. International Journal of Drug Policy, 19(Suppl. 1), 59-64.
16. Ezard, N. (2001). Public health, human rights and the harm reduction paradigm: From risk reduction to vulnerability reduction. International Journal of Drug Policy, 12, 207-219. (Pubitemid 32772599)
17. Government of India. Constitution of India. Retrieved September 22, 2008, from http://indiacode.nic.in.
18. Government of India, Central Bureau of Health Intelligence, Directorate General of Health Services,Ministry of Health and Family welfare. Regulation of medical practitioners in India. Retrieved March 1, 2010, from http://www.hum.au.dk/hsre/Docs/ Presentations/4 Regulation- scope%20and%20limitations/1 Ashok Kumar Regulation.pdf
19. Grund, J. P., Stern, L. S., Kaplan, C. D., Adriaans, N. F., & Drucker, E. (1992). Drug use contexts and HIV-consequences: The effect of drug policy on patterns of everyday drug use in Rotterdam and the Bronx. British Journal Addiction, 7(3), 381-392.
20. Gruskin, S., Feguson, L., Peersman, G., & Rugg, D. (2009). Human rights in the global response toHIV: Findings from the 2008 United Nations General assembly session reports. Journal of Acquired Immune Deficiency Syndromes, 52, S104-S110.
21. Gruskin, S., & Tarantola, D. (2008). Universal access to HIV prevention, treatment and care-assessing the inclusion of human rights in international and national strategic plans. AIDS, 22(Suppl. 2), 123-132.
22. Hammett, T.,Wu, Z., Duc, T. T., Stephens, D., Sullivan, S., Liu,W., et al. (2008). 'Social evils' and harm reduction: The evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction, 103(1), 137-145. (Pubitemid 350233419)
23. Heimer, R., Kaplan, E. H., Khoshnood, K., Jariwala, B.,&Cadman, E. C. (1993). Needle exchange decreases the prevalence of HIV-1 ProviralDNAin returned syringes inNewHaven, Connecticut. The American Journal of Medicine, 95, 214-220. (Pubitemid 23242716)
24. Hurley, S. F., Jolley, D. J., & Kaldor, J. M. (1997). Effectiveness of needle-exchange programmes for prevention of HIV infection. The Lancet, 349, 1797-1800. (Pubitemid 27257556)
25. Des Jarlais, D. C., Marmor, M., Paone, D., Titus, S., Shi, Q., Perlis, T., et al. (1996). HIV incidence among injecting drug users in New York City syringe-exchange programmes. The Lancet, 348, 987-991. (Pubitemid 26340754)
26. Kaplan, E. H., & Heimer, R. (1995). HIV incidence among New Haven needle exchange participants: Updated estimates from syringe tracking and testing data. Journal of Acquired Immune Deficiency Syndromes, 10, 175-176.
27. Kerr, T., Wood, E., Grafstein, E., Ishida, T., Shannon, K., Lai, C., et al. (2005). High rates of primary care and emergency department use among injecting drug users in Vancouver. Journal of Public Health (Oxford), 27(1), 62-66. (Pubitemid 40469260)
28. Krieger, N. (1999). Embodying inequality: A review of concepts, measures, and methods for studying health consequences of discrimination. International Journal of Health Services, 29(2), 295-352. (Pubitemid 29275379)
29. Ljungberg, B., Christensson, B., Tunving, K., Andersson, B., Landvall, B., Lundberg,M., et al. (1991).HIV prevention among injecting drug users: Three years of experience from a syringe exchange program in Sweden. Journal of Acquired Immune Deficiency Syndromes, 4, 890-895.
30. Maher, L. D., & Dixon, D. (1999). Policing and public health: Law enforcement and harm minimization in a street-level drug market. British Journal of Criminology, 39(4), 488-512.
31. Malekinejad, M., Johnston, L. G., Kendall, C., Kerr, L. R., Rifluin, M. R., & Rutherford, G. W. (2008). Using respondent driven sampling methodology for HIV biological and behavioral surveillance in international settings-A systematic review. AIDS and Behavior, 12(Suppl. 4), 105-130.
32. Mann, J. M. (1998). Dignity and health: The UDHR's revolutionary first article. Health and Human Rights, 3(2), 30-38.
33. Mathers, B. M., Degenhardt, L., Ali, H., Wiessing, L., Hickman, M., Mattick, R. P., et al. (2010). HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage. Lancet, 375, 1014-1028.
34. Moyer, L. B., Brouwer, K. C., Brodine, S. K., Ramos, R., Lozada, R., Cruz, M. F., et al. (2008). Barriers and missed opportunities to HIV testing among injection drug users in two Mexico-US border cities. Drug and Alcohol Review, 27(1), 39-45.
35. National AIDS Control Organisation. (2007). National AIDS control policy III. Retrieved September 4, 2008. www. nacoonline.org
36. National Human Rights Commission. (2008). NHRC's recommendations on HIV/AIDS. Retrieved August 12, 2008. http://nhrc.nic.in
37. North East India Harm Reduction Network (2006). Documenting testimonies within a rights based framework. Draft report. Imphal, Manipur: North East India Harm Reduction Network.
38. Panda, S., & Sharma, M. (2006). Needle syringe acquisition and HIV prevention among injecting drug users: A treatise on the good and not so good public health practices in South Asia. Substance Use & Misuse, 41(6), 953-977. (Pubitemid 43995142)
39. Paone, D., Des Jarlais, D. C., & Shi, Q. (1998). Syringe exchange use and HIV risk reduction over time. AIDS, 12, 121-123. (Pubitemid 28021329)
40. Peak, A., Rana, S., Maharjan, S. H., Jolley, D., & Crofts, N. (1995). Declining risk for HIV among injecting drug users in Kathmandu, Nepal: The impact of a harm-reduction programme. Acquired Immune Deficiency Syndromes, 9, 1067-1070.
41. Physician for Human Rights. (2003). PLWA form to study access to health care for people living with HIV and AIDS in Nigeria. Retrieved July 2, 2008, from http://physiciansforhumanrights.Org
42. Reddy, A., Hoque, M. M., & Kelly, R. (2008). HIV transmission in Bangladesh: An analysis of IDU programme coverage. International Journal of Drug Policy, 19(Suppl. 1), 37-46.
43. Rhodes, T., Singer, M., Bourgois, P., Friedman, S. R., & Strathdee, S. A. (2005). The social structural production of HIV risk among injecting drug users. Social Science & Medicine, 61(5), 1026-1044. (Pubitemid 40805548)
44. Rhodes, T., Mikhailova, L., Sarang, A., Lowndes, C. M., Rylkov, A., Khutorskoy,M., et al. (2003). Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliati City. Social Science and Medicine, 57(1), 39-54.
45. Sharan (2000). Rapid Situation Assessment of Drug Use in Delhi. Draft Report. New Delhi: Sharon-Society for service to urban poverty.
46. Sharan & Hopkins. (2007). Dissemination workshop report: Evaluation of a three component IDU Intervention in India. Dissemination workshop, New Delhi, India: Draft Report, September 27th.
47. Singer, M., Himmelgreen, D., Weeks, M. R., Radda, K. E., & Martinez, R. (1997). Changing the environment of AIDS risk: Findings on syringe exchange and pharmacy sales of syringes in Hartford, CT. Medical anthropology. Medical Anthropology, 18, 107-130. (Pubitemid 127822121)
48. Solomon, S. S., Celentano, D. D., Srikrishnan, A. K., Vasudevan, C. K., Anand, S., Kumar, M. S., et al. (2009). Mortality among injection drug users in Chennai, India (2005-2008). Acquired Immune Deficiency Syndromes, 23(8), 997-1004.
49. The Hindu. (2009). Indian Medical Association launches drive against quacks. Retrieved March 25, 2010, from http://www.thehindu.com/2009/09/15.
50. The Times of India. (2010, March 17). Drive is on to rid Belgaum of quacks. Retrieved March 25, 2010, from http://www. timesofindia.com
51. United Nations. (1995) Universal declaration of human rights. Retrieved September 25, 2008, from http://www.ohchr. org/EN/UDHR
52. United Nations Human Rights Commission 1976). International covenant on civil and political rights. Retrieved September 22, 2008, from http://www.unhcr.org/refworld/docid/ 3ae6b3aa0.html
53. United Nations Office for Drug and Crime. (2002). Rapid Assessment survey of Drug abuse in India. New Delhi: Office of UNODC.
54. Vlahov, D., Junge, B., Brookmeyer, R., Cohn, S., Riky, E., Armenian, H., et al. (1997). Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. Journal of Acquired Immune Deficiency Syndromes, 16, 400-406.
55. Weatherburn, D.,&Lind, B. (1997). The impact of lawenforcement activity on a heroin market. Addiction, 92(5), 557-569. (Pubitemid 27226598)
56. Wodak, A. (1998). Health, HIV infection, human rights and injecting drug use. Health and Human Rights, 2(4), 25-41. (Pubitemid 128630316)
57. Wolfe, D. (2007). Paradoxes in antiretroviral treatment for injecting drug users: Access, adherence and structural barriers in Asia and the former Soviet Union. International Journal of Drug Policy, 18(4), 246-254. (Pubitemid 47135597)
58. Wolfe, D., & Malinowska-Sempruch, K. (2007). Seeing double: Mapping contradictions in HIV prevention and illicit drug policy worldwide. In Chris Beyrer & H. F. Pizer (Eds.), Public health & human rights: Evidence based approaches (pp. 330-361). Baltimore, MD: The Johns Hopkins University Press.
59. Wood, E., Tyndall, M.W., Spittal, P. M., Li, K., Anis, A. H., Hogg, R. S., et al. (2003). Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: Investigation of a massive heroin seizure. Canadian Medical Association Journal, 168(2), 165-169. (Pubitemid 36126779)
60. World Health Organization. (1987). World Health Assembly, resolutionWHA40.26, global strategy for the prevention and control of AIDS. WHO, Geneva, May 5, 1987.